Antisense oligonucleotide therapy for splicing defects in OPA1-related dominant optic atrophy

被引：0
|
作者：
Wissinger, B. [1 ]
Synofzik, M. [2 ]
Schols, L. [2 ]
Bonifert, T. [1 ]
机构：
[1] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany
[2] Univ Tubingen, Dept Neurodegenerat Dis, Hertie Inst Clin Brain Res, Tubingen, Germany
来源：
ACTA OPHTHALMOLOGICA | 2017年 / 95卷
关键词：
D O I：
10.1111/j.1755-3768.2017.03173
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The natural history of OPA1-related autosomal dominant optic atrophy
    Cohn, A. C.
    Toomes, C.
    Hewitt, A. W.
    Kearns, L. S.
    Inglehearn, C. F.
    Craig, J. E.
    Mackey, D. A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (10) : 1333 - 1336
  • [2] OPA1-Related Syndrome Lacking Optic Atrophy
    Milone, Margherita
    Younge, Brian
    Wang, Jing
    Zhang, Shulin
    Wong, Lee-Jun
    NEUROLOGY, 2009, 72 (11) : A22 - A22
  • [3] Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy
    Lodi, R
    Tonon, C
    Valentino, ML
    Lotti, S
    Clementi, V
    Malucelli, E
    Barboni, P
    Longanesi, L
    Schimpf, S
    Wissinger, B
    Baruzzi, A
    Barbiroli, B
    Carelli, V
    ANNALS OF NEUROLOGY, 2004, 56 (05) : 719 - 723
  • [4] OPA1-related dominant optic atrophy is not strongly influenced by mitochondrial DNA background
    Pierron, Denis
    Ferre, Marc
    Rocher, Christophe
    Chevrollier, Arnaud
    Murail, Pascal
    Thoraval, Didier
    Amati-Bonneau, Patrizia
    Reynier, Pascal
    Letellier, Thierry
    BMC MEDICAL GENETICS, 2009, 10
  • [5] Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy
    Verny, C.
    Loiseau, D.
    Scherer, C.
    Lejeune, P.
    Chevrollier, A.
    Gueguen, N.
    Guillet, V.
    Dubas, F.
    Reynier, P.
    Amati-Bonneau, P.
    Bonneau, D.
    NEUROLOGY, 2008, 70 (13) : 1152 - 1153
  • [6] Deficit of in vivo mitochondrial ATP production in patients with OPA1-related autosomal dominant optic atrophy
    Lodi, R
    Tonon, C
    Iotti, S
    Clementi, V
    Malucelli, E
    Valentino, ML
    Barboni, P
    Longanesi, L
    Wissinger, B
    Schimpf, S
    Barbiroli, B
    Carelli, V
    NEUROLOGY, 2004, 62 (07) : A18 - A19
  • [7] OPA1 trans-splicing: A gene therapy approach to treat OPA1-related optic neuropathies
    le Dantec, Yannick
    Baris, Olivier
    Lenaers, Guy
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [8] Identification of biomarkers reflecting OPA1-related Dominant Optic Atrophy severity to infer patient cohorts eligible to clinical trials
    Bouzidi, Aymane
    Eckmann-Hansen, Christina
    Larsen, Mickael
    Zanlonghi, Xavier
    Bocquet, Beatrice
    Meunier, Isabelle
    Lenaers, Guy
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2024, 1865 : 20 - 21
  • [9] Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for the treatment of autosomal dominant optic atrophy
    Venkatesh, Aditya
    Li, Zhiyu
    Christiansen, Anne
    Lim, Kian Huat
    Kach, Jacob
    Hufnagel, Robert
    Aznarez, Isabel
    Liau, Gene
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [10] Antisense Oligonucleotide Mediated Increase of OPA1 Expression Using TANGO Technology for the Treatment of Autosomal Dominant Optic Atrophy
    Venkatesh, Aditya
    Li, Zhiyu
    Ali, Syed
    Christiansen, Anne
    Lim, Kian Huat
    Kach, Jacob
    Hufnagel, Robert B.
    Hoger, Jeffery H.
    Aznarez, Isabel
    Liau, Gene
    MOLECULAR THERAPY, 2020, 28 (04) : 112 - 112
12345